Varda Space Industries Successfully Receives Clearance to Bring Drug Manufacturing Spacecraft Back to Earth
After a prolonged period of waiting, Varda Space Industries has finally obtained the necessary approvals from regulators to bring its inaugural spacecraft back to Earth. The spacecraft, named Winnebago, was launched eight months ago as part of a SpaceX Transporter mission. Originally planned for a return in July, the spacecraft remained in orbit as Varda navigated the regulatory process required for reentry.
The anticipated landing of the Winnebago capsule is scheduled to take place on February 21 at the Utah Test and Training Range operated by the Air Force. Onboard the capsule are valuable pharmaceutical crystals of the drug Ritonavir, used in the treatment of HIV/AIDS, that were produced in the microgravity environment of space. Accompanying the Winnebago is Rocket Lab’s Photon spacecraft, which will disintegrate upon reentering Earth’s atmosphere.
Expressing gratitude for the collaboration with governmental authorities, Varda emphasized their commitment to safe innovation within the United States. The El Segundo-based startup highlights its pioneering status as the first entity to apply for reentry authorization under the newly established FAA regulations known as Part 450. Additionally, Varda holds the distinction of being the maiden commercial organization to secure a permit for conducting a spacecraft landing on U.S. territory, as opposed to the customary oceanic landings.
Varda stands among a select group of companies actively exploring the possibilities of manufacturing materials in the microgravity setting of space, particularly pharmaceutical products. As part of its strategic objectives, the company aims to bring spacecraft carrying manufactured goods back to Earth as frequently as once a month by 2026. Looking ahead, Varda has disclosed intentions to land its second spacecraft at the Koonibba Test Range in Australia for an upcoming mission set to launch this year.